Search

everythinglearnresearchcommunity

for

Search:↓

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

5α-Reductase inhibitors can negatively impact sexual function.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Finasteride safely treats enlarged prostate and male-pattern baldness.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.